Free Access
Med Sci (Paris)
Volume 21, Number 4, Avril 2005
Page(s) 349 - 351
Section Nouvelles
Published online 15 April 2005
  1. Flynn JL, Goldstein MM, Chan J, et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2 : 561–72. [Google Scholar]
  2. Jacobs M, Marino MW, Brown N, et al. Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation. Lab Invest 2000; 80 : 901–14. [Google Scholar]
  3. Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997; 388 : 394–7. [Google Scholar]
  4. Abel B, Thieblemont N, Quesniaux VJ, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169 : 3155–62. [Google Scholar]
  5. Reiling N, Holscher C, Fehrenbach A, et al. Cutting edge : Toll-like receptor (TLR)2- and TLR4-mediated pathogen recognition in resistance to airborne infection with Mycobacterium tuberculosis. J Immunol 2002; 169 : 3480–4. [Google Scholar]
  6. Sugawara I, Yamada H, Li C, et al. Mycobacterial infection in TLR2 and TLR6 knockout mice. Microbiol Immunol 2003; 47 : 327–36. [Google Scholar]
  7. Drennan MB, Nicolle D, Quesniaux VJ, et al. Toll-like receptor 2-deficient mice succumb to Mycobacterium tuberculosis infection. Am J Pathol 2004; 164 : 49–57. [Google Scholar]
  8. Fremond CMC, Nicolle DMM, Torres DS, Quesniaux VFJ. Control of Mycobacterium bovis BCG infection with increased inflammation in TLR4-deficient mice. Microbes Infect 2003; 5 : 1070. [Google Scholar]
  9. Nicolle D, Fremond C, Pichon X, et al. Long-term control of Mycobacterium bovis BCG infection in the absence of Toll-like receptors (TLRs) : Investigation of TLR2-, TLR6-, or TLR2-TLR4-deficient mice. Infect Immun 2004; 72 : 6994–7004. [Google Scholar]
  10. Nicolle DM, Pichon X, Bouchot A, et al. Chronic pneumonia despite adaptive immune response to Mycobacterium bovis BCG in MyD88-deficient mice. Lab Invest 2004; 84 : 1305–21. [Google Scholar]
  11. Fremond CM, Yeremeev V, Nicolle DM, et al. Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88. J Clin Invest 2004; 114 : 1790–9. [Google Scholar]
  12. Doherty TM, Arditi M. TB, or not TB : That is the question - Does TLR signaling hold the answer ? J Clin Invest 2004; 114 : 1699–703. [Google Scholar]
  13. Means TK, Wang S, Lien E, et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999; 163 : 3920–7. [Google Scholar]
  14. Quesniaux VJ, Nicolle DM, Torres D, et al. Toll-like receptor 2 (TLR2)-dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans. J Immunol 2004; 172 : 4425–34. [Google Scholar]
  15. Yamada H, Mizumo S, Horai R, et al. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/béta double-knockout mice. Lab Invest 2000; 80 :759–67. [Google Scholar]
  16. Juffermans NP, Florquin S, Camoglio L, et al. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis. J Infect Dis 2000; 182 : 902–8. [Google Scholar]
  17. Sugawara I, Yamada H, Kaneko H, et al. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice. Infect Immun 1999; 67 : 2585–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.